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Abstract 
Close  examination  of  a  67-year-old
Japanese man, who complained of persistent
nocturia,  revealed  that  a  semitransparent
polypoid tumor had developed from the blad-
der neck to the prostatic urethra obstructing
the internal urethral meatus, which resulted
in excessive urinary retention and post-renal
dysfunction.  The  tumor  was  resected  by  a
transurethral  procedure  and  a  pathological
examination  of  specimens  revealed  aggres-
sive  angiomyxoma  (AAM)  of  the  prostate.
AAM usually develops in the intrapelvic and
perineal organs of females. So far as we know,
this is the second case of primary prostatic
AAM reported in the English literature, and is
the first case where the patient encountered
urethral obstruction.
Introduction
We  experienced  a  case  where  urinary
retention  was  caused  by  a  tumor  of  the
prostate  of  unusual  origin.  This  neoplasm
appeared  translucent  and  characteristically
gelatinous on sectioning. Pathological exam-
ination identified the neoplasm as an aggres-
sive angiomyxoma (AAM), which is a benign
non-epithelial tumor with a high incidence in
the  pelvis  and  perineum  of  premenopausal
females.
1 Of the limited cases found in males,
only one AAM case has indicated a prostatic
origin to date.
2 Although AAM does not gener-
ally cause urethral, rectal, vaginal, or vascular
obstruction,
3 we encountered a case with urin-
ary retention owing to AAM. In this report, we
pursued the clinical course of a patient with
this  extremely  rare  disease  and  briefly
reviewed the relevant literature.
Case Report
In March 2007, a 67-year old Japanese man
without previous physical or surgical history
visited  our  hospital  after  suffering  from
intractable nocturia for six months. Although
digital  rectal  examination  showed  a  mildly
enlarging  prostate,  transrectal  or  transab-
dominal  ultrasonic  examination  revealed
excessive urinary retention with subsequent
bilateral  hydronephrosis  where  a  polypoid
mass (size: 2 cm) protruding into the cavity
was located in the bladder neck. According to
routine blood tests, the serum creatinine level
had  increased  to  1.71  mg/mL  and  prostatic
specific antigen registered 0.364 ng/mL. The
results of remaining blood tests were within
the normal range and urine cytology showed
no atypical cells. Flexible cystoscopy demon-
strated that a marshmallow-like translucent
protuberance developed from the left prostat-
ic urethra and protruded into the bladder cav-
ity (Figure 1A and B). 
In April 2007 we performed transurethral
resection under a clinical diagnosis of benign
prostatic hypertrophy (BPH) without conduct-
ing  other  diagnoses,  although  its  external
appearance  was  quite  contrary  to  the  BPH
image. The inner part of the tumor was jelly-
like, fairly transparent, elastic, and soft. Some
fine arteries from the prostate were seen pene-
trating  the  tumor  body  in  straight  lines
(Figure 1C). Since the boundary between the
tumor and prostatic tissue was indistinct and
arteries could have coursed from the prostate
tissue directly to the tumor through the dis-
tinct border, the tumor was most likely to have
developed from deep within the prostatic tis-
sue.  Therefore,  the  tumor  and  surrounding
normal tissue were resected as extensively as
possible in our surgical intervention.
Pathological examination of the AAM spe-
cimen revealed that the tumor consisted of
scattered  spindle  cells  and  myxoid  stroma
that stained positively with Alcian blue, with-
out  a  definite  boundary  discriminating  the
surrounding  prostatic  glands  (Figure  2).
Additionally,  immunohistochemical  staining
demonstrated  that  the  spindle  cells  reacted
positively  for  vimentin,  androgen  receptor,
and progesterone receptor, while was weakly
positive for MIB-1 and negative for desmin,
the estrogen receptor, CD34, and S-100 pro-
tein. 
After surgical intervention, the patient was
relieved from urinary difficulty and renal fail-
ure, and follow-up examinations (up to the
time when the present manuscript was under
preparation; >15 months) indicated no signs
of recurrence.
Discussion
AAM  is  a  benign  non-epithelial  tumor,
which was originally reported by Steeper and
Rosai  in  1983.
1 The  adjective  “aggressive”
added to the pathological name in spite of its
benign nature is because of its high risk of
local recurrence after resection.
1 Except in a
few cases,
4 the prognosis of AAM is generally
favorable  owing  to  a  lack  of  distant  metas-
tases.  AAM,  characterized  by  components
including myxoid stroma and scattered spin-
dle-shaped cells, is believed to be of fibroblast
or  myofibroblast  origin  by  ultrastructural
analysis. According to a recent immunohisto-
chemical  profile,  the  response  of  relevant
tumor cells is positive for vimentin; variable
for  desmin,
5 muscle-specific  actin,
1,5,6 and
CD34;
5 and negative for S-100 protein.
5
The  following  myxoid  soft  tissue  tumors
need to be distinguished from AAM: organ-
nonspecific  stromal  tumors  including  intra-
muscular  myxoma,  neurofibroma,  neuro-
thekeoma,  angiomyofibroblastoma,  superfi-
cial angiomyxoma, myxoid liposarcoma, myx-
oid  malignant  fibrous  histiocytoma,  and
embryonal rhabdomyosarcoma;
7 and prostate-
specific stromal tumors such as pure special-
ized stromal tumors of the prostate unassoci-
ated  with  sarcomas,
8 and  prostatic  stromal
hyperplasia with atypia.
9 However, the clinico-
pathological features of our case were conclu-
sive  evidence  to  diagnose  and  discriminate
AAM from other previously mentioned myxoid
tumors; as follows: a gross appearance that
resembled jelly; low cellularity; lack of cytolog-
ical atypia; lack of aggressive behavior sug-
gesting  malignancy,  such  as  necrosis  and
mitosis;  an  ill-defined  border;  lack  of
immunoreactivity  for  desmin,
9 S-100,  and
CD34;
10 and characteristic features of other
stromal components, such as numerous size-
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variable vessels with thin to thick walls and
hyalinization of larger vessels.
Although AAM often develops in the female
pelvis or perineum,
1,4 twenty-four male cases
have  been  reported  cumulatively  in  the
English  literature  until  2006.
2,3,6,7,11,12 The
affected  common  sites  in  these  patients
include the scrotum, spermatic cord, inguinal
region, and pelvis.
13 AAM of prostatic origin is
rare, and there have been no reports except a
Bastian’s case.
2 The AAM sites are limited to
the  reproductive  areas,  and  the  predomin-
ance of AAM in premenopausal females sug-
gests that certain hormonal factors may par-
ticipate in the development or proliferation of
AAM.  In  fact,  estrogen  and  progesterone
receptors have been identified and confirmed
in  more  than  90%  of  female  tissues.
4
Additionally, Htwe et al. have reported a case
where  AAM  is  aggravated  by  pregnancy.
11
However, AAM expresses androgen instead of
estrogen receptors in some male cases
12 and
in our case. Interestingly, the age range of
both the Bastian’s case and our patient over-
lapped  that  most  relevant  to  BPH.
Additionally,  coexistent  BPH  tissue  in  our
case  also  exhibited  androgen  receptors.
Therefore,  a  certain  androgen-dependent
mechanism  might  have  promoted  prolifer-
ation and growth of AAM as well as BPH via
the androgen receptor.
According to these findings on the hormon-
al environment, conservative treatment using
gonadotrophin-releasing  hormone  (Gn-RH)
agonists has been attempted against recur-
rent  tumors  with  encouraging  results.
13
Although such favorable findings have been
established,  the  current  therapy  prefers  a
local  extensive  resection  per  se.
6 The
approach  with  such  an  extensive  surgical
intervention, however, remains controversial.
Since AAM generally grows slowly as a benign
neoplasm and it is difficult to excise exten-
sively around the pelvis-perineal region with-
out inflicting injury on the adjacent organs,
urgent and complete resection is not always
established.  Furthermore,  postoperative
options in follow-up treatment are controver-
sial.  According  to  Behrankawala  and
Thomas,
14 long-term follow-up by careful clin-
ical examination is necessary, although regu-
lar imaging is not a prerequisite.
In our present case study, any symptoms or
signs of recurrence were screened carefully
and verified accordingly, using periodical sur-
veys  that  included  transrectal  ultrasonog-
raphy, because it might be difficult to discrim-
inate  symptoms  and/or  signs  of  AAM  from
those of BPH in the event that our patient
complained of any such AAM symptoms.
In conclusion, we need to take AAM of the
prostate  into  consideration  as  a  possible
cause  of  urinary  difficulty  including  reten-
tion, although this may be extremely rare. A
reliable diagnosis of AAM of the prostate may
lead to an optimal treatment and prevention
of its recurrence.
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hyalinization  around  them  (arrow).  (B)
Although hyperplasic prostatic glands (*)
were seen in the periphery of the figure,
there was no apparent boundary between
the myxoid lesion and proper prostatic tis-
sue. (Hematoxylin and eosin stain.)
A
A
B
B
C[Rare Tumors 2010; 2:e15] [page 45]
follow-up study of 18 cases. Arch Pathol
Lab Med 2008;132:1729-33.
10. Gaudin PB, Rosai J, Epstein JI. Sarcomas
and related proliferative lesions of spe-
cialized prostatic stroma: a clinicopatho-
logic study of 22 cases. Am J Surg Pathol
1998;22:148-62. 
11. Htwe  M,  Deppisch  LM,  Saint-Julien  JS.
Hormone-dependent aggressive angiomy-
xoama of the vulva. Obstet Gynecol 1995;
86:697-9.
12. Chihara Y, Fujimoto K, Takada S, et al.
Aggressive angiomyxoma in the scrotum
expressing  androgen  and  progesterone
receptors. Int J Urol 2003;10:672-5.
13. Fine BA, Munoz AK, Litz CE, et al. Primary
medical  management  of  recurrent
aggressive  angiomyxoma  of  the  vulva
with  a  gonadotropin-releasing  hormone
agonist. Gynecol Oncol 2001;81:120-2.
14. Behrankawala  KA,  Thomas  JM.
‘Aggressive’  angiomyxoma:  a  distinct
clinical entity. Eur J Surg Oncol 2003;29:
559-63.
Case Report